Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,995 | 13,097 | 13,848 | 14,927 | 16,156 |
| TOTAL | $12,871 | $13,653 | $14,167 | $15,376 | $16,889 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 844 | 1,067 | 1,406 | 1,092 | 1,095 |
| TOTAL | $844 | $1,067 | $1,406 | $1,092 | $1,095 |
| Total Assets | $13,716 | $14,720 | $15,573 | $16,468 | $17,984 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 259 | 287 | 203 | 473 | 281 |
| Accrued Expenses | 597 | 786 | 848 | 807 | 783 |
| TOTAL | $856 | $1,073 | $1,051 | $1,279 | $1,063 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $856 | $1,073 | $1,051 | $1,279 | $1,063 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,517 | 1,517 | 1,517 | 1,432 | 1,432 |
| Common Shares | 15 | 2 | 14 | 14 | 14 |
| Retained earnings | -189,956 | -189,100 | -187,617 | -186,813 | -184,141 |
| Other shareholders' equity | -28 | -28 | -27 | -25 | -28 |
| TOTAL | $12,859 | $13,647 | $14,522 | $15,192 | $16,920 |
| Total Liabilities And Equity | $13,716 | $14,720 | $15,573 | $16,471 | $17,984 |